Introduction: Kikuchi-Fujimoto disease (KFD) is a rare benign disease with a self-limiting course. Patients usually present with clinical features of tender cervical lymphadenopathy (LAP), fever, malaise, weight loss, and night sweats. The disease may mimic infective LAP or lymphoma on clinical and histopathological examination (HPE). Case Report: We report a case of 3-year-old male child who presented to us with bilateral cervical LAP not responding to conservative management. Excision biopsy was done and HPE revealed KFD. Conclusion: Clinicians should have high index of suspicion for diagnosis of KFD in patients with cervical LAP not responding to conservative management. Excision biopsy is important for accurate diagnosis and to avoid aggressive interventions like chemotherapy.

Kikuchi-Fujimoto disease (KFD) or Kikuchi necrotizing lymphadenitis was first described by Kikuchi and Fujimoto in 1972 in Japan [1]. It is a type of histiocytic necrotizing lymphadenitis which is benign and self-limiting. It is predominantly seen in adult females of Asian origin and is rarely seen in Western countries. It is characterized by tender cervical lymphadenopathy (LAP) and flu-like symptoms. The etiopathogenesis of KFD is still not clear, but various infectious agents like Toxoplasma gondii, Yersenia enterocolitica, human herpesvirus 6 & 8, hepatitis-B, and Epstein-Barr virus have been implicated [2-4]. The role of immunological mechanisms has also been proposed for the pathogenesis of KFD. The patients can be misdiagnosed as either systemic lupus erythematosus or lymphoma, and it becomes imperative to diagnose KFD to avoid unnecessary interventions. We report a rare case of KFD in a male child.

A 3-year-old male child presented to ENT Department of Atal Bihari Vajpayee institute of medical sciences and Dr Ram Manohar Lohia Hospital (ABVIMS & Dr RMLH), New Delhi, with swelling over the right side of the neck for the past 3 days and fever and lethargy for the past 1 day. He had a history of night sweats and excessive crying. Patient was febrile with no signs of dehydration. Examination revealed diffuse inflammatory swelling of the right side of neck extending from just below the angle of mandible to the level of hyoid bone. Swelling was tender but non-fluctuant.

Ultrasonography (USG) neck revealed bilateral multiple non-necrotic cervical LAP involving level 1b, 2, 3, 4 and 5, with conglomeration but maintained fatty hilum. Largest lymph node was seen at level 2 which measured 18 mm in maximum diameter. There was no suppuration/collection on USG neck. USG abdomen was normal.

The patient was severely anemic, and erythrocyte sedimentation rate (ESR) was found to be increased on complete blood count (CBC). Leukocytosis with increased polymorphs was identified initially which progressed to increase in lymphocytes over time (shown in Table 1).

Table 1.

Showing the results of serial CBC

Showing the results of serial CBC
Showing the results of serial CBC

Mantoux test was negative and chest X-ray posteroanterior view was normal. All viral markers were found to be nonreactive, and routine urine examination was also normal. Lactate dehydrogenase level was increased.

Intravenous ceftriaxone was started half gram twice a day, and vancomycin was added later on after pediatrician advice. The patient showed no signs of improvement even after 4 days of conservative management, and therefore, lymph node excision biopsy was done under general anesthesia (shown in Fig. 1).

Fig. 1.

Lymph node excision biopsy under GA. GA, general anesthesia.

Fig. 1.

Lymph node excision biopsy under GA. GA, general anesthesia.

Close modal

No pathogen or tubercular granulomas were seen on histopathological examination (HPE). The same showed effaced architecture with large areas of paracortical necrosis with abundant karyorrhectic debris, scattered fibrin deposits, and mononuclear cells. Many plasmacytoid dendritic cells were seen. Ziehl–Neelsen (ZN) stain for acid fast was negative. No atypical cells were observed. Overall morphology was suggestive of Kikuchi necrotizing lymphadenitis (shown in Fig. 2a–d).

Fig. 2.

a, b Multiple pale circumscribed foci of necrotic lesions, giving starry sky appearance. c, d Karyorrhectic debris, histiocytes, fibrin deposits, and plasmacytoid monocytes along with activated lymphoid cells.

Fig. 2.

a, b Multiple pale circumscribed foci of necrotic lesions, giving starry sky appearance. c, d Karyorrhectic debris, histiocytes, fibrin deposits, and plasmacytoid monocytes along with activated lymphoid cells.

Close modal

The patient was started on oral ibuprofen. The patient recovered completely with improvement in fever and pain after 4 weeks of treatment. Antinuclear antibody titers came out to be normal. Patient is under our regular follow-up for past 3 months, and there is no evidence of any complication or recurrence.

KFD is a benign, self-limiting rare cause of unilateral cervical LAP. The size of lymph node is usually 1–4 cm, but cases up to 8 cm have been reported. Occasional cases show involvement of mediastinal, peritoneal, retroperitoneal, and inguinal regions. The patient often presents with low-grade fever, malaise, oral ulcers, joint pains, and hepatosplenomegaly. CBC usually shows mild leucopenia with increased ESR and C-reactive protein levels; however, in our case, the patient presented with leukocytosis. The serological tests, including autoimmune antibodies and urine examination, are usually normal.

KFD may be associated with Epstein-Barr virus, implanted pacemakers, meningitis, breast cancer, and buccal cancer [2, 5]. The diagnosis is confirmed on HPE. KFD resolves spontaneously within a few months. According to available literature, KFD is a benign disease, but some proportion of people may develop complications like pulmonary hemorrhage, fatal hemophagocytic syndrome, and heart failure [6]. The treatment is essentially symptomatic with analgesics and antipyretics. Good results have also been reported with intravenous immune globulins in patients with severe symptoms; however, the role of antibiotics is controversial.

KFD is a rare benign cause of LAP. It should always be considered as a differential diagnosis in cases of LAP with generalized symptoms of malaise, fever, and lethargy. It may mimic tubercular LAP or malignant lymphoma, and HPE is essential for accurate diagnosis and to avoid aggressive treatment. An early diagnosis will prevent the patient from mental, financial, and emotional stress. Long-term follow-up is important as patients may develop systemic lupus erythematosus or lymphoproliferative malignant disease later in life.

Written and informed consent was obtained from the patient’s father to publish the case. Also, approval was obtained from the Institution Ethics Committee, ABVIMS & RML Hospital, for reporting the case.

The authors have no conflicts of interest to declare.

The authors did not receive any funding.

S.G.: writing – original draft preparation and visualization. A.G.: writing – reviewing and editing. K.S.: supervision. P.S.: investigation.

1.
Menasce
LP
,
Banerjee
SS
,
Edmondson
D
,
Harris
M
.
Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): continuing diagnostic difficulties
.
Histopathology
.
1998 Sep
;
33
(
3
):
248
54
.
2.
Ifeacho
S
,
Aung
T
,
Akinsola
M
.
Kikuchi-Fujimoto disease: a case report and review of the literature
.
Cases J
.
2008
;
1
(
1
):
187
9
.
3.
Bowman
JJ
,
Hee
CQ
.
Kikuchi’s lymphadenitis: cervical lymphadenopathy suggestive of acute lymphoma
.
ANZ J Surg
.
2007
;
77
(
5
):
403
4
.
4.
Hudnall
SD
,
Chen
T
,
Amr
S
,
Young
KH
,
Henry
K
.
Detection of human herpesvirus DNA in Kikuchi-Fujimoto disease and reactive lymphoid hyperplasia
.
Int J Clin Exp Pathol
.
2008
;
1
(
4
):
362
8
.
5.
Quadri
F
,
Atkin
GK
,
Das
SK
.
Kikuchi’s disease: an important cause of cervical lymphadenopathy
.
Clin Med
.
2007
;
7
(
1
):
82
4
.
6.
Perry
AM
,
Choi
SM
.
Kikuchi-Fujimoto disease: a review
.
Arch Pathol Lab Med
.
2018 Nov
;
142
(
11
):
1341
6
.
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.